COVID-19 is characterized by unique hyperinflammatory signatures across all types of immune cells, particularly the upregulation of TNF-α-, IL-6-, and IL-1-driven inflammatory responses in severe disease (35). This evidence concerns the gene IL1B and COVID-19.